FDA Proposes New Classification for NAC Supplement

The proposed rule would make N-acetyl-L-cysteine the agency's first ingredient classified as a Dietary Ingredient Not Excluded from the Dietary Supplement Definition.

Updated on Nov. 16, 2026 in Nutrition

FDA Proposes New Classification for NAC Supplement

Live Poll

Do you trust over-the-counter supplements like NAC to be safe?

The Food and Drug Administration proposed a new classification for N-acetyl-L-cysteine (NAC), a substance widely sold over-the-counter. The move addresses a legal gray area that has existed for years around the ingredient.

Why it matters

FDA rules prohibit the agency from including approved drugs in the dietary supplement category, and the agency previously approved NAC as a drug. The proposed classification is intended to resolve that conflict for an ingredient already on store shelves.

The FDA's two prior drug approvals, in 1963 for lung conditions and 1974 for acetaminophen overdose, are the basis for the current classification question. The extraction does not specify the proposed rule's timeline or final status.

The players

Food and Drug Administration

The FDA is the U.S. federal agency responsible for regulating drugs, dietary supplements, and food safety.

The details

The proposed rule would classify NAC as the agency's first "Dietary Ingredient Not Excluded from the Dietary Supplement Definition." The classification responds to the legal gray area that has allowed NAC to be widely sold over-the-counter.

Timeline

  1. 1963: FDA approves NAC as a drug to break up mucus in certain lung conditions.

  2. 1974: FDA approves NAC as a drug to treat acetaminophen overdose.

  3. November 16, 2026: FDA proposes the new classification for NAC.

Big Picture

The proposal operates within the federal dietary supplement definition, which excludes approved drugs, and reconciles that rule with NAC's earlier approvals as a drug. It is the agency's first use of this specific classification category.

Shoppers who buy NAC over the counter may see changes to how the ingredient is labeled or sold if the proposal is finalized. The extraction does not confirm any change to availability or price.

The takeaway

The FDA's proposal shows how a single ingredient can fall between drug and supplement rules, and why its regulatory status can change what consumers find on store shelves. Readers buying NAC should watch for the final rule and any label changes that follow.

Further reading

Explore more on Nutrition to see how supplement classification rules affect the products on store shelves.

Source note: This article includes information reported by STAT.

Live Poll

Do you trust over-the-counter supplements like NAC to be safe?